Roche’s fenebrutinib shows unprecedented positive phase III results as the potential first and only BTK inhibitor in both relapsing and primary progressive multiple sclerosis ...

Panel recommends DoP to consider better control over prices of non-scheduled formulations: Gireesh Babu, New Delhi Tuesday, November 11, 2025, 08:00 Hrs [IST] Raising concerns ove ...

Shardul Nautiyal, Mumbai Tuesday, November 11, 2025, 08:00 Hrs [IST] ...

Nandita Vijayasimha, Bengaluru Tuesday, November 11, 2025, 08:00 Hrs [IST] ...

Exports of Ayush and herbal products have reported a decline of 3.3% during the first half of the fiscal year 2025-26, compared to the same period of previous fiscal year. Exports during the quarter ...

IPDA calls for dedicated ministry for pharmaceuticals & establishment of National Pharmacy Commission: Peethaambaran Kunnathoor, Chennai Tuesday, November 11, 2025, 08:00 Hrs [IST ...

Cordis unveils positive results from SELUTION DeNovo and SELUTION4ISR randomized trials at TCT 2025: Our Bureau, Mumbai ...

Gilead announces phase 3 ASCENT-07 study of Trodelvy versus chemotherapy to treat post-endocrine therapy in HR+/HER2-negative metastatic breast cancer fails to meet the primary en ...

Organon to divest its JADA System for up to $465 million to Laborie Medical Technologies: Jersey City, New Jersey Monday, November 10, 2025, 14:00 Hrs [IST] Organon, a global heal ...

Cyber crime involving Rs. 2.16 crore as fraudsters intercept emails between Group Pharmaceuticals and Dr Reddy's Labs: Our Bureau, Bengaluru Monday, November 10, 2025, 17:15 Hrs [ ...

Takeda presents new data showing mezagitamab sustained effect on kidney function 18 months after treatment in primary IgA nephropathy: Osaka, Japan Monday, November 10, 2025, 15:0 ...

HBA 2025 India Leadership Summit in Mumbai discusses talent development in healthcare and pharma: Our Bureau, Mumbai Monday, November 10, 2025, 17:30 Hrs [IST] The Healthcare Busi ...